Praveen Radhakrishnan
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Prolyl Hydroxylase Inhibition Mitigates Allograft Injury During Liver Transplantation.
Journal: Transplantation
Published: July 18, 2022
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.
Journal: JCI insight
Published: July 20, 2021
Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses.
Journal: JCI insight
Published: April 15, 2020
Prognostic value of DLGAP5 in colorectal cancer.
Journal: International journal of colorectal disease
Published: June 19, 2019
Prolyl Hydroxylase Inhibition Mitigates Pouchitis.
Journal: Inflammatory bowel diseases
Published: May 20, 2019
Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
Journal: PloS one
Published: September 25, 2018
High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.
Journal: British journal of cancer
Published: September 13, 2018
Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells.
Journal: The American journal of pathology
Published: June 15, 2017
Pharmacological HIF-inhibition attenuates postoperative adhesion formation.
Journal: Scientific reports
Published: March 30, 2017
Last Updated: 09/26/2026